IL191846A0 - Substituted imidazoquinolines imidazonaphthyridines, and imidazopyridines, compositions, and methods - Google Patents
Substituted imidazoquinolines imidazonaphthyridines, and imidazopyridines, compositions, and methodsInfo
- Publication number
- IL191846A0 IL191846A0 IL191846A IL19184608A IL191846A0 IL 191846 A0 IL191846 A0 IL 191846A0 IL 191846 A IL191846 A IL 191846A IL 19184608 A IL19184608 A IL 19184608A IL 191846 A0 IL191846 A0 IL 191846A0
- Authority
- IL
- Israel
- Prior art keywords
- imidazonaphthyridines
- imidazopyridines
- compositions
- methods
- substituted imidazoquinolines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75139205P | 2005-12-16 | 2005-12-16 | |
| PCT/US2006/048017 WO2007075468A1 (en) | 2005-12-16 | 2006-12-15 | Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL191846A0 true IL191846A0 (en) | 2008-12-29 |
Family
ID=38218311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL191846A IL191846A0 (en) | 2005-12-16 | 2008-05-29 | Substituted imidazoquinolines imidazonaphthyridines, and imidazopyridines, compositions, and methods |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1968587A1 (en) |
| JP (1) | JP2009519955A (en) |
| KR (1) | KR20080077982A (en) |
| CN (1) | CN101330916A (en) |
| AU (2) | AU2006332000A1 (en) |
| CA (1) | CA2634017A1 (en) |
| IL (1) | IL191846A0 (en) |
| MX (1) | MX2008007864A (en) |
| NO (1) | NO20082757L (en) |
| WO (1) | WO2007075468A1 (en) |
| ZA (1) | ZA200805105B (en) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1653914A4 (en) | 2003-08-12 | 2008-10-29 | 3M Innovative Properties Co | Oxime substituted imidazo-containing compounds |
| NZ545412A (en) | 2003-08-27 | 2008-12-24 | Coley Pharm Group Inc | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| CA2537763A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for cd5+ b cell lymphoma |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| BRPI0414856A (en) | 2003-10-03 | 2006-11-21 | 3M Innovative Properties Co | alkoxy-substituted imidazoquinolines |
| CN1906193A (en) | 2003-11-14 | 2007-01-31 | 3M创新有限公司 | Oxime substituted imidazo ring compounds |
| CA2545825A1 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
| MXPA06005910A (en) | 2003-11-25 | 2006-08-23 | 3M Innovative Properties Co | Substituted imidazo ring systems and methods. |
| WO2005066170A1 (en) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| JP2007517044A (en) | 2003-12-30 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinylsulfonamide |
| AU2005228150A1 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| WO2006065280A2 (en) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| JP5313502B2 (en) | 2004-12-30 | 2013-10-09 | スリーエム イノベイティブ プロパティズ カンパニー | Substituted chiral condensed [1,2] imidazo [4,5-c] cyclic compounds |
| EP1831226B1 (en) | 2004-12-30 | 2012-08-08 | 3M Innovative Properties Company | Chiral tetracyclic compounds inducing interferon biosynthesis |
| US9248127B2 (en) | 2005-02-04 | 2016-02-02 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
| CA2597587A1 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
| JP2008538550A (en) | 2005-04-01 | 2008-10-30 | コーリー ファーマシューティカル グループ，インコーポレイテッド | 1-Substituted pyrazolo (3,4-c) cyclic compounds as modulators of cytokine biosynthesis for treating viral infections and neoplastic diseases |
| AU2006232377A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| GB0919423D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| TW201129565A (en) | 2010-01-12 | 2011-09-01 | Hoffmann La Roche | Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| JP5863058B2 (en) * | 2010-05-17 | 2016-02-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 1H-imidazo [4,5-c] quinoline |
| CA2805608A1 (en) | 2010-07-16 | 2012-01-19 | Piramal Enterprises Limited | Substituted imidazoquinoline derivatives as kinase inhibitors |
| KR20130087020A (en) * | 2010-09-16 | 2013-08-05 | 허치슨 메디파르마 리미티드 | Fused heteroaryls and their uses |
| CN103124731B (en) * | 2010-09-16 | 2016-01-20 | 和记黄埔医药（上海）有限公司 | The heteroaryl compound condensed and application thereof |
| GB201106799D0 (en) | 2011-04-21 | 2011-06-01 | Glaxosmithkline Llc | Novel compounds |
| GB201114103D0 (en) | 2011-08-17 | 2011-09-28 | Glaxosmithkline Llc | Novel compounds |
| US9227969B2 (en) | 2013-08-14 | 2016-01-05 | Novartis Ag | Compounds and compositions as inhibitors of MEK |
| EP3992191A1 (en) | 2020-11-03 | 2022-05-04 | Deutsches Krebsforschungszentrum | Imidazo[4,5-c]quinoline compounds and their use as atm kinase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1590348A1 (en) * | 2002-12-20 | 2005-11-02 | 3M Innovative Properties Company | Aryl / hetaryl substituted imidazoquinolines |
| EP1653914A4 (en) * | 2003-08-12 | 2008-10-29 | 3M Innovative Properties Co | Oxime substituted imidazo-containing compounds |
| AR048289A1 (en) * | 2003-12-04 | 2006-04-19 | 3M Innovative Properties Co | ETERES OF RING IMIDAZO SULFONA REPLACED. |
| JP2007517044A (en) * | 2003-12-30 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinylsulfonamide |
-
2006
- 2006-12-15 EP EP06845602A patent/EP1968587A1/en not_active Withdrawn
- 2006-12-15 MX MX2008007864A patent/MX2008007864A/en unknown
- 2006-12-15 KR KR1020087014349A patent/KR20080077982A/en not_active Application Discontinuation
- 2006-12-15 AU AU2006332000A patent/AU2006332000A1/en not_active Abandoned
- 2006-12-15 CA CA002634017A patent/CA2634017A1/en not_active Abandoned
- 2006-12-15 CN CNA2006800474919A patent/CN101330916A/en active Pending
- 2006-12-15 WO PCT/US2006/048017 patent/WO2007075468A1/en active Application Filing
- 2006-12-15 JP JP2008545861A patent/JP2009519955A/en active Pending
-
2008
- 2008-05-29 IL IL191846A patent/IL191846A0/en unknown
- 2008-06-11 ZA ZA200805105A patent/ZA200805105B/en unknown
- 2008-06-18 NO NO20082757A patent/NO20082757L/en not_active Application Discontinuation
-
2011
- 2011-04-04 AU AU2011201519A patent/AU2011201519A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1968587A1 (en) | 2008-09-17 |
| CN101330916A (en) | 2008-12-24 |
| AU2011201519A1 (en) | 2011-04-21 |
| MX2008007864A (en) | 2009-03-04 |
| JP2009519955A (en) | 2009-05-21 |
| ZA200805105B (en) | 2009-06-24 |
| NO20082757L (en) | 2008-09-04 |
| CA2634017A1 (en) | 2007-07-05 |
| AU2006332000A1 (en) | 2007-07-05 |
| KR20080077982A (en) | 2008-08-26 |
| WO2007075468A1 (en) | 2007-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200805105B (en) | Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods | |
| EP1765348A4 (en) | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines | |
| IL198509A0 (en) | Azaindole derivatives, compositions containing the same and uses thereof | |
| IL198250A0 (en) | Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b | |
| IL208220A0 (en) | Substituted imidazoquinolines, compositions comprising the same and uses thereof | |
| ZA200708028B (en) | Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists | |
| TWI347842B (en) | Tricyclic compounds, compositions, and methods | |
| HK1129305A1 (en) | Substituted 4-amino-pyrrolo-triazine derivatives 4-- | |
| IL186126A0 (en) | Pyridine-3-carboxamide derivatives as cb1 inverse agonists | |
| HUS2000022I1 (en) | Tiglien-3-one derivatives | |
| EP1895838A4 (en) | Compositions and methods | |
| ZA200806809B (en) | Pyridine-2-carboxamide derivatives | |
| EP1878727A4 (en) | 2-aminoquinazoline derivatives | |
| GB0601143D0 (en) | Uses, methods and compositions | |
| HK1115321A1 (en) | Camptothecin derivatives as chemoradiosensitizing agents | |
| IL192092A0 (en) | Aryl-isoxazolo-4-yl-oxadiazole derivatives | |
| ZA200707141B (en) | Pyridine-2-Carboxamide derivatives as mGluR5 antagonists | |
| EP1962852A4 (en) | Compounds, compositions and methods | |
| IL184841A0 (en) | Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives | |
| IL192235A0 (en) | Aryl-isoxazol-4-yl-imidazole derivatives | |
| ZA200903175B (en) | Spiro-piperidine derivatives | |
| HK1122797A1 (en) | Derivatives of pyrido | |
| IL182739A0 (en) | Acylatednonadepsipeptides used as lysobactin derivatives | |
| IL191138A0 (en) | Pyrazoloisoquinoline derivatives | |
| TWI339663B (en) | Spiro-piperidine derivatives |